The primary ICD-10-CM code for an adverse effect of steroids—specifically glucocorticoids and synthetic analogues—when used correctly as prescribed is T38.0X5. This code requires a seventh character (A, D, or S) to indicate the encounter type and must be sequenced after the code for the specific clinical manifestation or condition caused by the medication.
Steroids, particularly corticosteroids like prednisone, dexamethasone, and hydrocortisone, are among the most frequently prescribed anti-inflammatory and immunosuppressive medications in modern medicine. However, their potent systemic effects often lead to a wide range of complications. For medical coders and healthcare providers in 2026, accurately documenting these adverse effects is essential for clinical tracking, risk adjustment, and reimbursement. This guide provides a deep dive into the nuances of coding steroid-related complications, focusing on the correct application of ICD-10-CM codes for adverse effects, poisoning, and secondary conditions.
Understanding the T38.0X5 Code Hierarchy
The ICD-10-CM system is highly structured, and selecting the code for steroid adverse effects requires navigating the "Table of Drugs and Chemicals." To arrive at T38.0X5, it is necessary to understand the breakdown of the code’s components:
- T38: This category covers "Poisoning by, adverse effect of and underdosing of hormones and their synthetic substitutes and antagonists, not elsewhere classified."
- T38.0: This subcategory specifically identifies "Glucocorticoids and synthetic analogues." This includes common medications such as methylprednisolone, prednisone, and triamcinolone.
- T38.0X: The "X" serves as a placeholder to maintain the required structure when the code needs a sixth or seventh character but does not have a defined fifth character in some contexts.
- T38.0X5: The fifth (in the context of the subcategory) or sixth digit "5" specifically denotes an adverse effect. In ICD-10-CM logic, an "adverse effect" occurs when a medication is taken correctly as prescribed by a physician, but the patient experiences an unwanted or harmful reaction.
The Role of the Seventh Character
Code T38.0X5 is incomplete without a seventh character. As of the 2026 coding guidelines, the following extensions must be applied based on the nature of the patient’s visit:
- A – Initial Encounter: Used while the patient is receiving active treatment for the adverse effect. This includes emergency department visits, surgical evaluation, or the first encounter with a new physician for the problem.
- D – Subsequent Encounter: Used for encounters after the patient has completed active treatment and is receiving routine care during the healing or recovery phase (e.g., follow-up visits or medication adjustments).
- S – Sequela: Used for complications or conditions that arise as a direct result of the adverse effect after the acute phase has passed (e.g., permanent scarring or organ damage resulting from a previous steroid-induced crisis).
Adverse Effect vs. Poisoning: Crucial Distinctions
A common error in medical billing is the confusion between an "adverse effect" and "poisoning." The ICD-10-CM guidelines are very strict regarding this distinction.
Adverse Effect (T38.0X5)
This code is used when a patient takes their prednisone or other glucocorticoid exactly as instructed, but they develop a complication like drug-induced Cushing's syndrome or steroid-induced hyperglycemia. The coding priority here is to code the manifestation first, followed by the T38.0X5 code.
Poisoning (T38.0X1 to T38.0X4)
Poisoning codes are used when the medication is taken incorrectly. This includes:
- T38.0X1: Accidental overdose or taking the wrong substance by mistake.
- T38.0X2: Intentional self-harm.
- T38.0X3: Assault (e.g., someone else administering the drug to cause harm).
- T38.0X4: Undetermined intent.
In poisoning cases, the T-code is sequenced first, followed by codes for the manifestations or symptoms.
Underdosing (T38.0X6)
If a patient takes less of a steroid than prescribed (either intentionally or unintentionally), and their original condition (like asthma or rheumatoid arthritis) worsens as a result, code T38.0X6 is used. This is never sequenced as a primary diagnosis.
Manifestation Coding: The "Code Also" Rule
When using T38.0X5, the ICD-10-CM instructional notes state that you must first code the nature of the adverse effect. Steroids affect almost every organ system, meaning the primary code will vary significantly depending on the patient's symptoms.
Common Steroid-Induced Manifestations and Their Codes
- Drug-Induced Cushing’s Syndrome (E24.3): This is one of the most common long-term side effects of systemic glucocorticoid therapy. Patients may present with a "moon face," buffalo hump, and central obesity.
- Steroid-Induced Diabetes Mellitus (E09.-): Steroids increase insulin resistance and glucose production in the liver. If a patient develops diabetes due to steroid use, you would use a code from category E09 (Drug or chemical induced diabetes mellitus). For example, E09.9 for drug-induced diabetes without complications.
- Steroid-Induced Osteoporosis (M81.8): Long-term steroid use inhibits bone formation. If the patient has a fracture, the code shifts to M80.8- (Other osteoporosis with current pathological fracture).
- Glaucoma Secondary to Drugs (H40.6-): Steroids can increase intraocular pressure.
- Steroid-Induced Myopathy (G72.0): Muscle weakness, particularly in the proximal limbs, is a known complication of high-dose corticosteroids.
Sequencing Example
If a patient is seen for a follow-up of steroid-induced hyperglycemia caused by correctly taking prescribed dexamethasone for brain swelling:
- Primary Code: E09.9 (Drug or chemical induced diabetes mellitus without complications)
- Secondary Code: T38.0X5D (Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter)
Anabolic Steroids vs. Glucocorticoids
It is vital to distinguish between corticosteroids (used for inflammation) and anabolic steroids (used for muscle growth or hormonal replacement).
- Glucocorticoids (Corticosteroids): Coded under T38.0.
- Anabolic Steroids: Coded under T38.7X5 for an adverse effect. These are "androgens and anabolic congeners."
Using the wrong category can lead to significant errors in clinical data and insurance denials, as the medical necessity for these two classes of drugs differs fundamentally.
Comparison of Steroid-Related ICD-10-CM Coding Scenarios
The following table outlines how to select the correct code based on the clinical scenario and the intent of medication use.
| Clinical Scenario | Primary Code Category | Secondary Code Category | Sequencing Rule |
|---|---|---|---|
| Adverse Effect (Prescribed dose, unwanted reaction) | The manifestation (e.g., E09.9, E24.3) | T38.0X5- | Manifestation first, T-code second. |
| Accidental Overdose (Patient took 2 pills instead of 1) | T38.0X1- | The manifestation or symptoms | T-code first, manifestation second. |
| Underdosing (Patient stopped taking steroids abruptly) | The condition being treated (e.g., M06.9) | T38.0X6- | Condition first, T-code second. |
| Chronic Use/History (Patient long-term user of steroids) | The condition being treated | Z79.51 or Z79.52 | Varies; Z-codes are usually supplemental. |
Documentation Requirements for 2026
To support the use of T38.0X5, the medical documentation in 2026 must be specific. Auditors look for the "linkage" between the drug and the condition.
Provider Documentation Checklist
- Identify the Drug: The specific steroid must be named (e.g., "Prednisone 20mg").
- Establish Causality: The provider must explicitly state that the condition (e.g., gastritis) is "due to," "caused by," or "secondary to" the steroid.
- Specify the Intent: Documentation should clearly show the drug was taken as prescribed to distinguish it from poisoning.
- Detail the Encounter: Note whether the patient is in the acute phase (Initial), recovering (Subsequent), or dealing with a late effect (Sequela).
For more detailed information on official coding guidelines, healthcare professionals should refer to the CMS ICD-10-CM Official Guidelines for Coding and Reporting.
Long-Term Use of Steroids (Z79.5)
If a patient is not currently experiencing an "adverse effect" but is on a long-term steroid regimen, the T38.0X5 code is not appropriate. Instead, clinicians should use "Z-codes" to indicate the patient’s status.
- Z79.51: Long-term (current) use of inhaled steroids.
- Z79.52: Long-term (current) use of systemic steroids (oral or IV).
These codes are crucial for 2026 Risk Adjustment Factor (RAF) scoring, as they indicate a patient with a higher complexity of care who requires frequent monitoring for potential side effects, even before those side effects manifest.
FAQs: Adverse Effects of Steroids
What is the 7th character for an adverse effect of steroids in an ER setting?
For a patient presenting to the emergency room for the first time with a steroid-induced adverse effect, the 7th character is A (Initial encounter). The full code would be T38.0X5A. This character remains "A" for the duration of the active, acute treatment phase, even if the patient is transferred from the ER to an inpatient unit.
Can I code T38.0X5 for steroid-induced weight gain?
While weight gain is a common side effect of steroids, it is generally considered a symptom rather than a formal diagnosis unless it reaches the level of morbid obesity or is part of Cushing's syndrome. If the physician diagnoses "Steroid-induced obesity," you would code the obesity (E66.x) first, followed by T38.0X5. If it is just noted as weight gain, code R63.5 (Abnormal weight gain) followed by the T-code.
How do I code for a patient who develops a rash from a steroid cream?
If a patient develops an allergic reaction or adverse effect from a topical corticosteroid (like hydrocortisone cream), you still use category T38.0. Specifically, you would code the dermatitis/rash first (such as L27.1, "Localized skin eruption due to drugs and medicaments taken internally" or L25.1, "Androgenic/chemical dermatitis due to drugs in contact with skin"), followed by T38.0X5.
Is there a difference between T38.0 and T38.0X?
In ICD-10-CM, many codes require a placeholder "X" to fill a specific character position so that the "intent" (the 6th character) and the "encounter type" (the 7th character) land in the correct spot. T38.0 is the subcategory; T38.0X5 is the specific code for an adverse effect, where the "X" is the necessary 4th-character placeholder.
What is the sequela code for steroid-induced avascular necrosis?
If a patient developed avascular necrosis (AVN) of the hip due to steroid use years ago and is now being seen for chronic pain related to that AVN, you would code the AVN (e.g., M87.151) first, followed by T38.0X5S. The "S" indicates that the current problem is a late effect or "sequela" of the earlier drug adverse effect.
Practical Recommendation for Coders and Clinicians
When documenting or billing for steroid-related issues in 2026, always prioritize the clinical manifestation. Use T38.0X5 as a secondary code to provide the "why" behind the condition. Ensure that the physician’s note clearly links the steroid use to the complication to avoid denials. If the patient is simply on long-term steroids without current adverse effects, use Z79.52 to capture the complexity of the patient's medication management without incorrectly implying an acute injury.
